Data / Form D filings / Propanc Biopharma, Inc.
Propanc Biopharma, Inc.: Form D filings
Propanc Biopharma, Inc., a pharmaceuticals company in Camberwell, Vic, Australia, filed 15 Form D notices with the SEC between 2012 and 2023. The latest, on November 3, 2023, reports $40,000 sold of a $40,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 302, 6 BUTLER STREET, Camberwell, Vic, Australia, 3124
- Phone
- +61-03-9882-0780
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1517681
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | New notice | $40,000 | $40,000 | 1 | Oct 20, 2023 | sec.gov | |
| Oct 26, 2023 | New notice | $61,000 | $61,000 | 1 | Oct 12, 2023 | sec.gov | |
| Aug 31, 2023 | New notice | $72,500 | $72,500 | 1 | Aug 23, 2023 | sec.gov | |
| Aug 31, 2023 | New notice | $55,000 | $55,000 | 1 | Aug 16, 2023 | sec.gov | |
| Aug 30, 2023 | New notice | $120,000 | $120,000 | 1 | Aug 15, 2023 | sec.gov | |
| Aug 16, 2023 | New notice | $65,000 | $65,000 | 1 | Jun 29, 2023 | sec.gov | |
| Aug 15, 2023 | New notice | $45,000 | $45,000 | 1 | Jul 19, 2023 | sec.gov | |
| Apr 17, 2020 | New notice | $450,000 | $450,000 | 1 | Apr 2, 2020 | sec.gov | |
| Jan 2, 2019 | New notice | $105,000 | $105,000 | 1 | Nov 30, 2018 | sec.gov | |
| Jan 2, 2019 | New notice | $126,000 | $126,000 | 1 | Dec 24, 2018 | sec.gov | |
| Oct 11, 2018 | New notice | $422,000 | $422,000 | 2 | Oct 2, 2018 | sec.gov | |
| Oct 1, 2018 | New notice | $6,315,435 | $6,315,435 | 8 | Sep 13, 2016 | sec.gov | |
| Sep 17, 2018 | New notice | $158,000 | $158,000 | 2 | Aug 28, 2018 | sec.gov | |
| May 8, 2013 | New notice | $1,500,000 | $0 | $1,500,000 | 0 | Yet to occur | sec.gov |
| Jun 4, 2012 | New notice | $7,500,000 | $30,000 | $7,470,000 | 10 | Apr 2, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Nathanielsz | Executive Officer, Director | |
| Josef Zelinger | Director | |
| Julian Kenyon | Executive Officer, Director |
Every Form D from the week of Oct 30, 2023 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Propanc Biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.